Point72 Europe »

Palvella Therapeutics Inc Ne shares owned by Point72 Europe

Quarter-by-quarter ownership of Palvella Therapeutics Inc Ne (PVLA) shares owned by Point72 Europe from 13F filings

Historical chart of Point72 Europe investment in Palvella Therapeutics Inc Ne

Tip: Access up to 7 years of quarterly data

All positions including Palvella Therapeutics Inc Ne held by Point72 Europe consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Palvella Therapeutics Inc Ne by Point72 Europe

Quarter filed Position value Share count Share price at filing
2025-09-30 $728 12 60.67

More positions owned by Point72 Europe

Strategy Cl A New (MSTR)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Meta Platforms Cl A (META)
Capital One Financial (COF)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Russell 2000 Etf (IWM)
Key (KEY)
Charles Schwab Corporation (SCHW)
TPG Com Cl A (TPG)
WESCO International (WCC)
Bank of America Corporation (BAC)
Regeneron Pharmaceuticals (REGN)
Suncor Energy (SU)
Linde SHS (LIN)

View all positions for Point72 Europe

Top funds holding Palvella Therapeutics Inc Ne

BVF
Suvretta Capital Management
Frazier Life Sciences Management
First Light Asset Management
Vanguard Group
BlackRock
State Street Corporation
Perceptive Advisors
Summit Partners Public Asset Management
Jennison Associates
Federated Investors
Woodline Partners
Artisan Partners Limited Partnership
MPM Oncology Impact Management
Caption Management

View all funds holding Palvella Therapeutics Inc Ne